Please join us for a virtual briefing by Covington's leading life sciences team providing an update on the Trump Administration’s Most-Favored-Nation (MFN) drug pricing initiative, and considerations for healthcare compliance, pricing, trade, litigation, antitrust, and other political, administrative, and regulatory changes.
Presenters
Grant Castle, Partner
gcastle@cov.com
TJ Garrigan, Senior Advisor
tgarrigan@cov.com
Kristie Gurley, Partner
kgurley@cov.com
Arun Venkataraman, Partner
avenkataraman@cov.com
Sibel Yilmaz, Partner
syilmaz@cov.com
Event Details:
Tuesday, December 9, 2025
11 a.m. – 1 p.m. EST
4 p.m. – 6 p.m. GMT
5 p.m. – 7 p.m. CET
Log-in details will be provided upon registration.
This invite only webinar is closed to media.
CLE: This program is pending accreditation for CLE in CA and NY (for both newly admitted and experienced attorneys). Credit will be applied as requested but cannot be guaranteed for VA or WA. The following jurisdictions may accept reciprocal credit: AZ, AR, CT, NJ, and HI. A general certificate of attendance and necessary materials will be provided for all other jurisdictions to support self-application.